Synthesis of some new N-(alkyl/aralkyl)-N-(2,3-dihydro-1,4-benzodioxan-6-yl)-4-chlorobenzenesulfonamides as possible therapeutic agents for Alzheimer's disease and Type-2 Diabetes. [electronic resource]
- Pakistan journal of pharmaceutical sciences Jan 2019
- 61-68 p. digital
Publication Type: Journal Article
1011-601X
Acetylcholinesterase--metabolism Alzheimer Disease--drug therapy Butyrylcholinesterase--metabolism Cholinesterase Inhibitors--chemical synthesis Diabetes Mellitus, Type 2--drug therapy Glycoside Hydrolase Inhibitors--chemical synthesis Mass Spectrometry Molecular Structure Proton Magnetic Resonance Spectroscopy Structure-Activity Relationship Sulfonamides--chemical synthesis alpha-Glucosidases--metabolism